Open/Close Menu True Medication Verification in Seconds!

WasteWitness®, PharmID’s drug diversion management system, was featured in Pharmacy Purchasing & Product Magazine’s December issue focused on diversion prevention. PPP’s December issue focuses on an urgent topic in healthcare: drug diversion prevention. At PharmID, we know healthcare can be safer with more powerful tools. Our mission is to make healthcare safer with true molecular…

Drug diversion prevention is an increasingly urgent topic in healthcare. The COVID-19 pandemic has impacted every aspect of hospital management, especially pharmacy. Drug diversion programs are under strain as resources are reallocated in the fight against COVID. As a result, the global pandemic has exacerbated issues like drug diversion. PharmID founders Barb Marquardt and Scott…

Published by Microsoft in March 2020: When an opportunity arose to reduce medication errors and prevent opioid theft using Raman spectroscopy technology licensed from MarqMetrix, Seattle-based PharmID used Windows 10 IoT Core, Azure, and Power BI Embedded to build the drug-verification solution WasteWitness. The app enables customers to easily verify if patients are being administered…

PharmID was honored at the 2020 Seattle Business Magazine Leaders in Health Care Awards as a top health care innovator in the state of Washington. Our team took home the Gold Award for Achievement in Medical Technology Award. The Leaders in Health Care Awards celebrate individuals and organizations that are leading the effort to advance Washington’s healthcare sector. PharmID leverages the power of MarqMetrix’s powerful Raman…

WasteWitness™, PharmID’s drug diversion management system, was featured in Pharmacy Purchasing & Product Magazine’s “New & Noteworthy.” WasteWitness provides molecular proof of diversion, backed by hard data captured during wasting events. The WasteWitness system rapidly analyzes medication using laser-based molecular technology to give drug and concentration verification. The pass or fail results are delivered to…

By Lynne Peeples, originally published in Pharmacy Technology Report. Raman spectroscopy, a technology long used by the pharmaceutical industry and academic laboratories, is emerging as a potential tool to detect and deter the diversion of controlled substances, according to a new study. The anti-diversion tool uses laser technology to analyze the chemical fingerprint of a…

PharmID will be exhibiting at the ASHP Midyear Meeting in Las Vegas, NV December 8–12 2019. Come by and visit us on the exhibit floor. We will be demonstrating our solution for monitoring the composition of controlled substance waste and returns, WasteWitness™

PharmID will be exhibiting at the IHFDA Annual Conference in Orlando, FL September 23–25 2019. Come by and visit us on the exhibit floor. We will be demonstrating our solution for monitoring the composition of controlled substance waste and returns, WasteWitness™

PharmID will be exhibiting at the ASHP Midyear Clinical Meeting in Anaheim December 3-5 2018. Come by and visit us at Booth 2003 on the exhibit floor. We will be demonstrating our new solution for monitoring the composition of controlled substance waste and returns, WasteWitness™

PharmID will be exhibiting at the ASHP Summer Meeting in Denver June 2-6 2018. Come by and visit us at Booth 805 on the exhibit floor. We will be demonstrating our new solution for monitoring the composition of controlled substance waste and returns, WasteWitness™